Lynchburg Journal of Medical Science
Going Off Script: An Update on Clinical Guidelines, Novel, Repurposed and Adjunct Drugs in the Treatment of Adults with Bipolar Disorder
Dr. Trey Boyd, DMSc, PA-C
Bipolar Disorder (BD) is a common diagnosis in behavioral/mental health practice, and despite a multifaceted approach to management: pharmacotherapy, psychotherapeutic, family and lifestyle interventions, electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), etc., management remains complex and unsatisfactory.Repurposing drugs for treatment is one of many promising approaches to this problem, and it is vital that providers remain current on novel, trial and evidence-based data in order to utilize optimal management strategies. Advanced practice providers (APPs) and physicians who work in behavioral medicine, primary/family medicine, internal medicine, emergency medicine, hospitalists and pharmacists will benefit from this article. Adults with BD and their families or caretakers may utilize this information as well. Guidelines and clinical practices as to the pharmacological treatment for BD are ever changing, as novel and repurposed drugs are approved for use or utilized for off-label management of this complex disorder. This article will aid providers in staying current on options and recommendations for optimal treatment.
Bernsohn TB. Going Off Script: An Update on Clinical Guidelines, Novel, Repurposed and Adjunct Drugs in the Treatment of Adults with Bipolar Disorder. Lynchburg Journal of Medical Science. 2022; 4(3).
Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.
Off-campus users can also use 'Off-campus Download' button above for access.